ABIOMED, Inc. (ABMD) Is At $296.32 Formed Wedge; ARM HOLDINGS PLC ORD 0.05P (LON:ARM) Had 13 Analysts Last Week

ABIOMED, Inc. (NASDAQ:ABMD) Logo

Among 27 analysts covering ARM Holdings PLC (LON:ARM), 13 have Buy rating, 2 Sell and 12 Hold. Therefore 48% are positive. ARM Holdings PLC had 199 analyst reports since July 22, 2015 according to SRatingsIntel. Deutsche Bank maintained the stock with “Hold” rating in Tuesday, July 19 report. The stock of ARM HOLDINGS PLC ORD 0.05P (LON:ARM) has “Sell” rating given on Thursday, November 5 by Liberum Capital. The stock of ARM HOLDINGS PLC ORD 0.05P (LON:ARM) earned “Outperform” rating by BNP Paribas on Tuesday, February 23. The company was maintained on Friday, August 21 by Bernstein. JP Morgan upgraded it to “Neutral” rating and GBX 850 target in Wednesday, September 2 report. As per Wednesday, January 27, the company rating was maintained by Liberum Capital. Beaufort Securities maintained ARM HOLDINGS PLC ORD 0.05P (LON:ARM) on Wednesday, September 16 with “Buy” rating. The stock of ARM HOLDINGS PLC ORD 0.05P (LON:ARM) has “Overweight” rating given on Monday, October 12 by Barclays Capital. The stock has “Conviction Buy” rating by Goldman Sachs on Thursday, July 23. As per Wednesday, September 16, the company rating was maintained by Credit Suisse. See ARM HOLDINGS PLC ORD 0.05P (LON:ARM) latest ratings:

ABIOMED, Inc. (ABMD) formed wedge up with $317.06 target or 7.00% above today’s $296.32 share price. ABIOMED, Inc. (ABMD) has $13.12 billion valuation. The stock decreased 0.14% or $0.42 during the last trading session, reaching $296.32. About 298,281 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 128.67% since April 17, 2017 and is uptrending. It has outperformed by 117.12% the S&P500.

The stock increased 0.11% or GBX 1.9 during the last trading session, reaching GBX 1701.9. About 33.23 million shares traded or Infinity% up from the average. ARM HOLDINGS PLC ORD 0.05P (LON:ARM) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Since February 20, 2018, it had 0 insider buys, and 1 sale for $5.41 million activity. Greenfield Andrew J sold $5.41 million worth of stock or 20,000 shares.

Investors sentiment decreased to 1.18 in Q4 2017. Its down 0.12, from 1.3 in 2017Q3. It is negative, as 19 investors sold ABIOMED, Inc. shares while 110 reduced holdings. 55 funds opened positions while 97 raised stakes. 36.44 million shares or 5.39% less from 38.51 million shares in 2017Q3 were reported. Castleark Mngmt Limited Liability Com accumulated 280,044 shares. Shaker Limited Liability Co Oh accumulated 28,233 shares. D E Shaw And has invested 0.02% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Primecap Management Ca owns 4.08 million shares. Gilder Gagnon Howe And Ltd Liability Corp invested in 19,851 shares. Advisor Ltd Liability stated it has 915 shares. Teachers Retirement Sys Of The State Of Kentucky, a Kentucky-based fund reported 8,690 shares. Rhenman Partners Asset Ab holds 86,490 shares. Advisory Net Ltd Liability Co invested in 433 shares or 0.01% of the stock. Goldman Sachs Inc holds 0.02% in ABIOMED, Inc. (NASDAQ:ABMD) or 508,949 shares. Regions holds 0% or 70 shares in its portfolio. Cambridge Invest Research Advsr Inc holds 8,787 shares or 0.02% of its portfolio. Trexquant Invest L P holds 0.2% or 9,567 shares. Chicago Equity Ptnrs Lc reported 0.01% stake. Cibc Markets holds 0.01% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 9,091 shares.

ABIOMED, Inc. (NASDAQ:ABMD) Institutional Positions Chart